​

TELA Bio (TELA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TELA Stock Forecast

TELA Bio (TELA) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $2.42, with a high of $3.00 and a low of $1.25. This represents a 114.16% increase from the last price of $1.13.

$1 $2 $3 $4 $5 $6 $7 High: $3 Avg: $2.42 Low: $1.25 Last Closed Price: $1.13

TELA Stock Rating

TELA Bio stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

TELA Price Target Upside V Benchmarks

TypeNameUpside
StockTELA Bio114.16%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts333
Avg Price Target$2.42$2.42$2.42
Last Closing Price$1.13$1.13$1.13
Upside/Downside114.16%114.16%114.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25131--5
Nov, 25131--5
Oct, 25131--5
Sep, 25131--5
Aug, 25131--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 01, 2025Frank TakkinenLoop Capital Markets$3.00$1.17156.41%165.49%
Dec 01, 2025Lake Street$3.00$1.24141.94%165.49%
Nov 14, 2025Piper Sandler$1.25$0.9334.41%10.62%
Oct 04, 2024Frank TakkinenLake Street$8.00$2.52217.46%607.96%
Aug 13, 2024Matt O'BrienPiper Sandler$8.00$4.0199.50%607.96%
May 22, 2024Kyle RoseCanaccord Genuity$14.00$6.20125.81%1138.94%
May 10, 2024Matt O'BrienPiper Sandler$10.00$5.7873.01%784.96%
Nov 10, 2022JMP Securities$20.00$8.10146.91%1669.91%
Nov 09, 2022Matt O'BrienPiper Sandler$15.00$6.50130.77%1227.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 01, 2025Lake StreetBuyBuyhold
Nov 14, 2025Piper SandlerNeutralNeutralhold
Oct 23, 2024Piper SandlerOverweightOverweighthold
Oct 04, 2024Piper SandlerMarket OutperformMarket Outperformhold
Oct 04, 2024Lake StreetBuyBuyhold
Oct 04, 2024Canaccord GenuityBuyBuyhold
Aug 13, 2024Piper SandlerOverweightOverweighthold
May 22, 2024Canaccord GenuityBuyBuyhold
May 10, 2024Piper SandlerOverweightOverweighthold
Nov 09, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.46$-2.49$-2.73$-2.04$-1.33----
Avg Forecast$-2.14$-2.18$-2.73$-1.93$-1.37$-0.61$-0.25$0.48$1.04
High Forecast$-2.09$-2.12$-2.71$-1.91$-1.29$-0.42$-0.15$0.48$1.05
Low Forecast$-2.17$-2.21$-2.75$-1.96$-1.45$-0.81$-0.35$0.48$1.03
Surprise %14.95%14.22%-5.70%-2.92%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$18.21M$29.46M$41.42M$58.45M$69.30M----
Avg Forecast$18.33M$29.04M$43.00M$57.95M$74.71M$93.83M$116.65M$148.23M$185.43M
High Forecast$18.58M$29.43M$43.31M$58.20M$75.21M$94.23M$116.65M$148.91M$186.29M
Low Forecast$18.00M$28.51M$42.74M$57.70M$74.22M$93.43M$116.64M$147.49M$184.51M
Surprise %-0.65%1.45%-3.68%0.87%-7.25%----

Net Income Forecast

$-65M $-47M $-29M $-11M $7M $25M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-31.88M$-36.11M$-44.34M$-46.66M$-37.84M----
Avg Forecast$-48.88M$-49.77M$-62.40M$-44.24M$-31.43M$-14.05M$-5.68M$10.97M$23.78M
High Forecast$-47.73M$-48.59M$-61.91M$-43.57M$-29.59M$-9.58M$-3.41M$11.04M$23.93M
Low Forecast$-49.73M$-50.63M$-62.99M$-44.92M$-33.26M$-18.53M$-7.95M$10.91M$23.63M
Surprise %-34.78%-27.44%-28.95%5.47%20.40%----

TELA Forecast FAQ

Is TELA Bio stock a buy?

TELA Bio stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that TELA Bio is a favorable investment for most analysts.

What is TELA Bio's price target?

TELA Bio's price target, set by 8 Wall Street analysts, averages $2.42 over the next 12 months. The price target range spans from $1.25 at the low end to $3 at the high end, suggesting a potential 114.16% change from the previous closing price of $1.13.

How does TELA Bio stock forecast compare to its benchmarks?

TELA Bio's stock forecast shows a 114.16% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for TELA Bio over the past three months?

  • December 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is TELA Bio’s EPS forecast?

TELA Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.61, marking a -54.14% decrease from the reported $-1.33 in 2024. Estimates for the following years are $-0.25 in 2026, $0.48 in 2027, and $1.04 in 2028.

What is TELA Bio’s revenue forecast?

TELA Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $93.83M, reflecting a 35.39% increase from the reported $69.3M in 2024. The forecast for 2026 is $116.65M, followed by $148.23M for 2027, and $185.43M for 2028.

What is TELA Bio’s net income forecast?

TELA Bio's net income forecast for the fiscal year ending in December 2025 stands at $-14.055M, representing a -62.86% decrease from the reported $-37.841M in 2024. Projections indicate $-5.677M in 2026, $10.97M in 2027, and $23.78M in 2028.